Annual Shareholders Equity
$463.44 M
-$22.37 M-4.60%
December 31, 2023
Summary
- As of February 12, 2025, RXRX annual stockholders equity is $463.44 million, with the most recent change of -$22.37 million (-4.60%) on December 31, 2023.
- During the last 3 years, RXRX annual shareholders equity has risen by +$669.73 million (+324.65%).
- RXRX annual shareholders equity is now -14.64% below its all-time high of $542.94 million, reached on December 31, 2021.
Performance
RXRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$524.56 M
-$59.89 M-10.25%
September 30, 2024
Summary
- As of February 12, 2025, RXRX quarterly stockholders equity is $524.56 million, with the most recent change of -$59.89 million (-10.25%) on September 30, 2024.
- Over the past year, RXRX quarterly shareholders equity has increased by +$123.41 million (+30.76%).
- RXRX quarterly shareholders equity is now -18.38% below its all-time high of $642.71 million, reached on June 30, 2021.
Performance
RXRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
RXRX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.6% | +30.8% |
| 3 y3 years | +324.6% | +8.0% |
| 5 y5 years | +472.9% | +8.0% |
RXRX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.6% | at low | -10.3% | +35.2% |
| 5 y | 5-year | -14.6% | +324.6% | -18.4% | +325.1% |
| alltime | all time | -14.6% | +324.6% | -18.4% | +325.1% |
Recursion Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $524.56 M(-10.2%) |
| Jun 2024 | - | $584.45 M(+45.7%) |
| Mar 2024 | - | $401.15 M(-13.4%) |
| Dec 2023 | $463.44 M(-4.6%) | $463.44 M(+5.8%) |
| Sep 2023 | - | $437.97 M(-6.6%) |
| Jun 2023 | - | $468.96 M(+9.0%) |
| Mar 2023 | - | $430.18 M(-11.5%) |
| Dec 2022 | $485.81 M | $485.81 M(+25.2%) |
| Sep 2022 | - | $388.03 M(-11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $437.58 M(-11.3%) |
| Mar 2022 | - | $493.57 M(-9.1%) |
| Dec 2021 | $542.94 M(-363.2%) | $542.94 M(-9.4%) |
| Sep 2021 | - | $599.03 M(-6.8%) |
| Jun 2021 | - | $642.71 M(-375.8%) |
| Mar 2021 | - | -$233.03 M(+13.0%) |
| Dec 2020 | -$206.29 M(+66.0%) | - |
| Dec 2020 | - | -$206.29 M |
| Dec 2019 | -$124.27 M | - |
FAQ
- What is Recursion Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual shareholders equity year-on-year change?
- What is Recursion Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Recursion Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of RXRX is $463.44 M
What is the all time high annual shareholders equity for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual stockholders equity is $542.94 M
What is Recursion Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, RXRX annual stockholders equity has changed by -$22.37 M (-4.60%)
What is Recursion Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of RXRX is $524.56 M
What is the all time high quarterly shareholders equity for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly stockholders equity is $642.71 M
What is Recursion Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, RXRX quarterly stockholders equity has changed by +$123.41 M (+30.76%)